
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | -- | -- | -- | $0.44 | -- |
08/06/2025 | Q2 | -- | -- | -- | $0.47 | -- |
05/02/2025 | Q1 | -- | $237.6M | $0.14 | $0.42 | -$0.28 |
02/24/2025 | Q4 | $1.1B | $290.1M | $0.43 | $0.37 | $0.06 |
11/05/2024 | Q3 | -- | $277M | $0.51 | $0.42 | $0.09 |
08/06/2024 | Q2 | -- | $284.2M | $0.41 | $0.45 | -$0.04 |
05/01/2024 | Q1 | -- | $284.7M | $0.42 | $0.45 | -$0.03 |
02/20/2024 | Q4 | -- | $297.3M | $0.41 | $0.47 | -$0.06 |
11/02/2023 | Q3 | -- | -- | $0.37 | $0.44 | -$0.07 |
08/03/2023 | Q2 | -- | -- | $0.34 | $0.39 | -$0.05 |
05/04/2023 | Q1 | -- | -- | $0.42 | $0.46 | -$0.04 |
02/21/2023 | Q4 | -- | -- | $0.48 | $0.47 | $0.01 |
11/03/2022 | Q3 | -- | -- | $0.42 | $0.47 | -$0.05 |
08/02/2022 | Q2 | -- | -- | $0.47 | $0.48 | -$0.01 |
05/03/2022 | Q1 | -- | -- | $0.46 | $0.57 | -$0.11 |
02/22/2022 | Q4 | -- | -- | $0.84 | $0.44 | $0.40 |
11/02/2021 | Q3 | -- | -- | $0.36 | $0.52 | -$0.16 |
08/03/2021 | Q2 | -- | -- | $0.71 | $0.56 | $0.15 |
05/04/2021 | Q1 | -- | -- | $0.43 | $0.52 | -$0.09 |
02/23/2021 | Q4 | -- | -- | $0.43 | $0.51 | -$0.08 |
11/03/2020 | Q3 | -- | -- | $0.53 | $0.46 | $0.07 |
08/06/2020 | Q2 | -- | -- | $0.43 | $0.47 | -$0.04 |
05/04/2020 | Q1 | -- | -- | $0.50 | $0.52 | -$0.02 |
02/18/2020 | Q4 | -- | -- | $0.49 | $0.48 | $0.01 |
11/05/2019 | Q3 | -- | -- | $0.42 | $0.48 | -$0.06 |
08/06/2019 | Q2 | -- | -- | $0.39 | $0.46 | -$0.07 |
05/02/2019 | Q1 | -- | -- | $0.46 | $0.41 | $0.05 |
02/19/2019 | Q4 | -- | -- | $0.37 | $0.46 | -$0.09 |
11/06/2018 | Q3 | -- | -- | $0.38 | $0.40 | -$0.02 |
08/02/2018 | Q2 | -- | -- | $0.40 | $0.46 | -$0.06 |
05/03/2018 | Q1 | -- | -- | $0.36 | $0.45 | -$0.09 |
02/20/2018 | Q4 | -- | -- | $0.46 | $0.46 | -$0.00 |
11/07/2017 | Q3 | -- | -- | -- | -- | -- |
08/03/2017 | Q2 | -- | -- | $0.36 | $0.42 | -$0.06 |
05/02/2017 | Q1 | -- | -- | $0.35 | $0.43 | -$0.08 |
02/21/2017 | Q4 | -- | -- | $0.39 | -- | -- |
11/08/2016 | Q3 | -- | -- | $0.32 | -- | -- |
07/28/2016 | Q2 | -- | -- | $0.34 | -- | -- |
05/03/2016 | Q1 | -- | -- | $0.45 | -- | -- |
02/23/2016 | Q4 | -- | -- | $0.40 | $0.42 | -$0.02 |
11/03/2015 | Q3 | -- | -- | $0.37 | $0.42 | -$0.05 |
Westlake Chemical Partners LP reported $237.6M worth of top line sales in its most recent quarter.
Westlake Chemical Partners LP announced earnings per share of $0.14 which represents a miss of analyst forecast a $0.42 per share.
Westlake Chemical Partners LP reported $54.1M that represents $1.53 per share over the last quarter.
Westlake Chemical Partners LP's earnings are forecast to decrease from $1.77 per share to $1.61 per share next year representing a decrease of -15.25%.
Westlake Chemical Partners LP's next earnings date is August 6, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.